{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:04:46Z","timestamp":1782601486812,"version":"3.54.5"},"reference-count":82,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.joms.2012.07.049","type":"journal-article","created":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T01:15:33Z","timestamp":1348017333000},"page":"513-519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Osteonecrosis of the Jaw Onset Times Are Based on the Route of Bisphosphonate Therapy"],"prefix":"10.1016","volume":"71","author":[{"given":"Kenneth E.","family":"Fleisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma Deepthi Chippada","family":"Venkata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Glickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2012.07.049_bib1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jamda.2007.06.005","article-title":"Update on osteoporosis in long-term care: Focus on bisphosphonates","volume":"8","author":"Kamel","year":"2007","journal-title":"J Am. Med Dir Assoc"},{"key":"10.1016\/j.joms.2012.07.049_bib2","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/sj.bjc.6604382","article-title":"Risks and benefits of bisphosphonates","volume":"98","author":"Coleman","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.joms.2012.07.049_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ctrv.2007.10.002","article-title":"New research findings on zoledronic acid: Survival, pain, and anti-tumour effects","volume":"34","author":"Saad","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.joms.2012.07.049_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.mlr.0000108746.69256.45","article-title":"Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions","volume":"42","author":"Weinfurt","year":"2004","journal-title":"Med Care"},{"key":"10.1016\/j.joms.2012.07.049_bib5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa0806285","article-title":"Endocrine therapy plus zoledronic acid in premenopausal breast cancer","volume":"360","author":"Gnant","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2012.07.049_bib6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.bjc.6605555","article-title":"Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk","volume":"102","author":"Newcomb","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.joms.2012.07.049_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/jnci\/djq114","article-title":"New studies support case for bisphosphonates as possible chemopreventive agent","volume":"102","author":"Schmidt","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.joms.2012.07.049_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1634\/theoncologist.2007-0152","article-title":"Cancer treatment-induced bone loss: Pathophysiology and clinical perspectives","volume":"13","author":"Brufsky","year":"2008","journal-title":"Oncologist"},{"issue":"suppl, abstr","key":"10.1016\/j.joms.2012.07.049_bib9","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1200\/jco.2011.29.15_suppl.8011","article-title":"Are there benefits to long-term bisphosphonate treatment in multiple myeloma (MM)?","volume":"29","author":"Davies","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2012.07.049_bib10","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/jop.2006.2.1.7","article-title":"Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer","volume":"2","author":"Ruggiero","year":"2006","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.joms.2012.07.049_bib12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bone.2008.01.003","article-title":"Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis","volume":"42","author":"Rizzoli","year":"2008","journal-title":"Bone"},{"issue":"abstr","key":"10.1016\/j.joms.2012.07.049_bib13","first-page":"18s","article-title":"A randomized phase III trial of denosumab versus zoledronic acid in patients with bone metastases from castration-resistant prostate cancer","volume":"28","author":"Fizazi","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2012.07.049_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bjoms.2009.08.030","article-title":"Osteonecrosis of the jaws induced by anti-RANK ligand therapy","volume":"48","author":"Taylor","year":"2010","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","article-title":"Osteonecrosis of the jaw in a patient on denosumab","volume":"68","author":"Aghaloo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.joms.2010.03.011","article-title":"How new knowledge sounds: Developing a contemporary understanding of osteonecrosis","volume":"68","author":"Assael","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib17","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/annonc\/mdn653","article-title":"Bevacizumab-associated osteonecrosis of the jaw","volume":"19","author":"Greuter","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.joms.2012.07.049_bib18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.14219\/jada.archive.2009.0280","article-title":"Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: A review","volume":"140","author":"Almazrooa","year":"2009","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.joms.2012.07.049_bib19","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ijom.2010.04.054","article-title":"Clinical comparison of patients with osteonecrosis of the jaws, with and without a history of bisphosphonates administration","volume":"39","author":"Kos","year":"2010","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.joms.2009.10.026","article-title":"Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction","volume":"68","author":"Saia","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib21","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bone.2009.07.011","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: A key role of inflammation?","volume":"45","author":"Lesclous","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.joms.2012.07.049_bib22","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1200\/JCO.2007.15.5424","article-title":"Osteonecrosis of the jaw related to bevacizumab","volume":"28","author":"Estilo","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2012.07.049_bib23","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.joms.2011.08.011","article-title":"Osteonecrosis of the maxilla associated with cancer chemotherapy in patients wearing dentures","volume":"70","author":"Infante-Cossio","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib24","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00432-010-0907-7","article-title":"Bisphosphonate-induced osteonecrosis of the jaw: A review of 2,400 patient cases","volume":"136","author":"Filleul","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.joms.2012.07.049_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.mehy.2011.11.011","article-title":"Is oral bisphosphonate-related osteonecrosis of the jaw an endemic condition?","volume":"78","author":"Diz","year":"2012","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.joms.2012.07.049_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.joms.2009.01.007","article-title":"The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: So many hypotheses, so few data","volume":"67","author":"Allen","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib27","first-page":"354","article-title":"Summary of ASBMR Task Force on ONJ","volume":"7","author":"Burr","year":"2007","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.joms.2012.07.049_bib28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1634\/theoncologist.2007-0159","article-title":"Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: A retrospective study","volume":"13","author":"Ibrahim","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.joms.2012.07.049_bib29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.critrevonc.2007.07.005","article-title":"Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?","volume":"64","author":"Diel","year":"2007","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1016\/j.joms.2012.07.049_bib30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1345\/aph.1H521","article-title":"Bisphosphonate-induced osteonecrosis of the jaw","volume":"41","author":"Krueger","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.joms.2012.07.049_bib31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1634\/theoncologist.2008-0091","article-title":"Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy","volume":"13","author":"Estilo","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.joms.2012.07.049_bib32","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.14219\/jada.archive.2005.0108","article-title":"Managing the care of patients with bisphosphonate-associated osteonecrosis: An American Academy of Oral Medicine position paper","volume":"136","author":"Migliorati","year":"2005","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.joms.2012.07.049_bib33","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1601-0825.2009.01581.x","article-title":"Dental management of patients at risk of osteochemonecrosis of the jaws: A critical review","volume":"15","author":"Fedele","year":"2009","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2012.07.049_bib34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.joms.2008.12.004","article-title":"Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Dodson","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib35","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2012.07.049_bib36","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","article-title":"Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors","volume":"24","author":"Badros","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2012.07.049_bib37","first-page":"968","article-title":"Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: Evidence of increased risk after treatment with zoledronic acid","volume":"91","author":"Dimopoulos","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.joms.2012.07.049_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.joms.2009.01.011","article-title":"Bisphosphonates\u2014What the dentist needs to know: Practical considerations","volume":"67","author":"Fantasia","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib39","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1200\/JCO.2011.35.1551","article-title":"Osteonecrosis of the jaw after zoledronic acid and denosumab treatment","volume":"29","author":"Fusco","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2012.07.049_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.joms.2009.01.003","article-title":"Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: Clinical findings, assessment of risks, and preventive strategies","volume":"67","author":"Assael","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib41","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.joms.2008.09.028","article-title":"The role of inferior alveolar nerve involvement in bisphosphonate-related osteonecrosis of the jaw","volume":"67","author":"Otto","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib42","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.joms.2008.02.012","article-title":"Nonexposed bisphosphonate-related osteonecrosis of the jaws: Another clinical variant?","volume":"66","author":"Junquera","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib43","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.joms.2008.09.031","article-title":"Sinus tracts\u2014An early sign of bisphosphonate-associated osteonecrosis of the jaws?","volume":"67","author":"Mawardi","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib44","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.joms.2010.05.003","article-title":"Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure","volume":"68","author":"Hutchinson","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib45","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1517\/14656566.9.8.1351","article-title":"Current knowledge and future directions on bisphosphonate-related osteonecrosis of the jaw in cancer patients","volume":"9","author":"Adamo","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.joms.2012.07.049_bib46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1196\/annals.1402.089","article-title":"Bisphosphonates: An update on mechanisms of action and how these relate to clinical efficacy","volume":"1117","author":"Russell","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.joms.2012.07.049_bib47","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib48","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.joms.2009.07.079","article-title":"Bisphosphonate-related osteonecrosis of the jaw: Is pH the missing part in the pathogenesis puzzle?","volume":"68","author":"Otto","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib49","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.joms.2010.06.210","article-title":"Bone scans, bisphosphonates, and a lack of acute changes within the mandible","volume":"69","author":"Morris","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib50","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1124\/dmd.108.021071","article-title":"Biodistribution and plasma protein binding of zoledronic acid","volume":"36","author":"Weiss","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.joms.2012.07.049_bib51","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00774-007-0837-x","article-title":"Ibandronate uptake in the jaw is similar to long bones and vertebrae in the rat","volume":"26","author":"Frieder","year":"2008","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.joms.2012.07.049_bib52","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bone.2008.09.012","article-title":"Osteonecrosis of the jaw: Who gets it, and why?","volume":"44","author":"Reid","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.joms.2012.07.049_bib53","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ncponc1000","article-title":"Bisphosphonates and osteomyelitis of the jaw: A pathogenic puzzle","volume":"4","author":"Bertoldo","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.joms.2012.07.049_bib54","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bone.2006.01.141","article-title":"Bisphosphonate actions: Physical chemistry revisited","volume":"38","author":"Papapoulos","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.joms.2012.07.049_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djq516","article-title":"Osteonecrosis of the jaw and the role of macrophages","volume":"103","author":"Pazianas","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.joms.2012.07.049_bib56","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jbmr.23","article-title":"Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats","volume":"25","author":"Hokugo","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2012.07.049_bib57","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bone.2010.04.588","article-title":"Histopathologic findings in bone from edentulous alveolar ridges: A role in osteonecrosis of the jaws?","volume":"47","author":"Kassolis","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.joms.2012.07.049_bib58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10555-011-9280-5","article-title":"Improving cancer immunotherapy by targeting tumor-induced immune suppression","volume":"30","author":"Stewart","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.joms.2012.07.049_bib59","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/(SICI)1097-0142(19990415)85:8<1843::AID-CNCR26>3.0.CO;2-R","article-title":"A prospective pilot study to evaluate a new dental assessment and treatment paradigm for patients scheduled to undergo intensive chemotherapy for cancer","volume":"85","author":"Toljanic","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.joms.2012.07.049_bib60","first-page":"466","article-title":"Periodontal infection in cancer patients treated with high-dose chemotherapy","volume":"10","author":"Raber-Durlacher","year":"2002","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.joms.2012.07.049_bib61","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00198-009-1018-7","article-title":"Immune changes in post-menopausal osteoporosis: The Immunos study","volume":"21","author":"Breuil","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.joms.2012.07.049_bib62","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1086\/648075","article-title":"Bisphosphonate-related osteonecrosis of the jaw: The role of actinomyces","volume":"49","author":"Naik","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.joms.2012.07.049_bib63","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1601-0825.2011.01848.x","article-title":"Antibiotic effects on bacterial profile in osteonecrosis of the jaw","volume":"18","author":"Ji","year":"2012","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2012.07.049_bib64","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.joms.2007.11.035","article-title":"Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy","volume":"66","author":"Sedghizadeh","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib65","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.14219\/jada.archive.2009.0049","article-title":"Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy","volume":"140","author":"Sedghizadeh","year":"2009","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.joms.2012.07.049_bib66","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0757.1994.tb00019.x","article-title":"The bacteria of periodontal disease","volume":"5","author":"Moore","year":"1994","journal-title":"Periodontol"},{"key":"10.1016\/j.joms.2012.07.049_bib67","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1128\/JB.183.12.3770-3783.2001","article-title":"Bacterial diversity in human subgingival plaque","volume":"183","author":"Paster","year":"2001","journal-title":"J Bacteriol"},{"key":"10.1016\/j.joms.2012.07.049_bib68","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1601-0825.2012.01916.x","article-title":"Molecular profiling of oral microbiota in jaw bone samples of bisphosphonate related osteonecrosis of the jaw","volume":"18","author":"Wei","year":"2012","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2012.07.049_bib69","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1158\/1078-0432.CCR-07-1430","article-title":"Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw","volume":"14","author":"Raje","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.joms.2012.07.049_bib70","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/CMR.10.2.320","article-title":"Bacterial persistence and expression of disease","volume":"10","author":"Domingue","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.joms.2012.07.049_bib71","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM197801122980206","article-title":"Microbial synergism in human infections (second of two parts)","volume":"298","author":"Mackowiak","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2012.07.049_bib72","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM197801052980105","article-title":"Microbial synergism in human infections (first of two parts)","volume":"298","author":"Mackowiak","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2012.07.049_bib73","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/bies.10233","article-title":"Nonculturable bacteria: Programmed survival forms or cells at death's door?","volume":"25","author":"Nystr\u00f6m","year":"2003","journal-title":"Bioessays"},{"issue":"suppl","key":"10.1016\/j.joms.2012.07.049_bib74","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ijantimicag.2007.06.024","article-title":"Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria","volume":"30","author":"Fenollar","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.joms.2012.07.049_bib75","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/0022034508328124","article-title":"The microbiota of acute apical abscesses","volume":"88","author":"Siqueira","year":"2009","journal-title":"J Dent Res"},{"key":"10.1016\/j.joms.2012.07.049_bib76","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1177\/0022034509346549","article-title":"Diversity of endodontic microbiota revisited","volume":"88","author":"Siqueira","year":"2009","journal-title":"J Dent Res"},{"key":"10.1016\/j.joms.2012.07.049_bib77","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: Different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.joms.2012.07.049_bib78","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jcms.2009.06.005","article-title":"Bisphosphonate-related osteonecrosis of the jaws: A review of 34 cases and evaluation of risk","volume":"38","author":"Kos","year":"2010","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib79","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","article-title":"Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates","volume":"23","author":"Hoff","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2012.07.049_bib80","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tripleo.2011.02.037","article-title":"Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: Prospective experience of a dental oncology referral center","volume":"112","author":"Nicolatou-Galitis","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.joms.2012.07.049_bib81","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","article-title":"Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","volume":"68","author":"Lo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2012.07.049_bib82","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","article-title":"Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw","volume":"27","author":"Vahtsevanos","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239112010907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239112010907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:41:32Z","timestamp":1759509692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239112010907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0278239112010907"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2012.07.049","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteonecrosis of the Jaw Onset Times Are Based on the Route of Bisphosphonate Therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2012.07.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}